Navigation Links
Genetic Engineering and Biotechnology News (GEN) Presents Exclusive Podcast with Robert Langer, Ph.D. on New Polymeric Drug Delivery Systems
Date:4/9/2008

NEW ROCHELLE, N.Y., April 9, 2008 /PRNewswire/ -- Genetic Engineering and Biotechnology News (GEN), http://www.genengnews.com will present a podcast with Robert Langer, Ph.D., on New Polymeric Drug Delivery Systems, on Thursday, April 10, 2008, 4 p.m. EDT

Dr. Langer is institute professor, chemical and biomedical engineering, Massachusetts Institute of Technology. "Robert Langer is the foremost pioneer and innovator in modern drug delivery," says John Sterling, Editor-in-Chief of Genetic Engineering and Biotechnology News. "Dr. Langer and his team continue to advance research and development on novel biomaterials and tissue- engineered products. They are constantly pushing the technology envelope for new ways to deliver biodrugs and pharmaceuticals."

This podcast is imperative for researchers and biotechnology, pharmaceutical and medical device executives whose companies are engaged in drug discovery and development, as well as market makers, analysts, and investors who must be knowledgeable about the challenges and directions in therapeutic delivery. The podcast will be featured until April 17th on http://www.genengnews.com and then archived on the site.

Dr. Langer has more than 600 issued or pending patents. The patents have been licensed or sublicensed to over 200 pharmaceutical, chemical, biotechnology, and medical device companies, many of which were launched on the basis of these patent licenses. He served as a member of the FDA's science advisory board from 1995-2002 and as chairman from Chairman from 1999-2002.

In this exclusive podcast, Dr. Langer discusses the drug-delivery projects currently drawing his team's attention in the laboratory. He addresses the application of nanotechnology to the creation of new drug delivery systems. In addition, he specifically looks at what gene therapy-technology must overcome before it can become a viable delivery system. Dr. Langer also will present an update on his group's work in the field of tissue engineering, including the recent creation of a Gecko-Inspired Bandage.

Genetic Engineering and Biotechnology News (GEN) is published in print 21 times a year by Mary Ann Liebert, Inc. (http://www.liebertpub.com) GEN's website, http://www.genengnews.com presents and updates news and financial information 24/7.

Contact: John Sterling, Editor-in-Chief, Genetic Engineering and Biotechnology News, jsterling@genengnews.com, Ph: 914.740-2196; Cell: 646.234-5118


'/>"/>
SOURCE Genetic Engineering and Biotechnology News
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform
2. Genetic Engineering & Biotechnology News reports on cancer biomarkers
3. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference
4. Interleukin Genetics Announces Conference Call and Webcast to Discuss Fourth Quarter and Year End 2007 Business Results
5. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
6. Interleukin Genetics Retains Top Life Science Communications Firms
7. On the trail of rogue genetically modified pathogens
8. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
9. deCODE Genetics Announces Full-year 2007 Financial Results
10. Genetic manipulation might model cystic fibrosis
11. NIOXIN(R) Delivers the Future to Scalp and Hair Care, Introduces the First Genetic Test to Determine the Likelihood of Hair Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator (YI) ... of the Class of 2016 were selected from a pool of 128 applicants ... the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
Breaking Biology News(10 mins):